Holen Sie sich die Stockscreener-App
14.53
9.47%
-1.52
Handel nachbörslich:
14.63
0.10
+0.69%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FMC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$16.05
Offen:
$15.96
24-Stunden-Volumen:
4.72M
Relative Volume:
1.00
Marktkapitalisierung:
$1.82B
Einnahmen:
$4.17B
Nettoeinkommen (Verlust:
$1.46B
KGV:
1.2504
EPS:
11.62
Netto-Cashflow:
$493.00M
1W Leistung:
+6.29%
1M Leistung:
-4.09%
6M Leistung:
-58.66%
1J Leistung:
-60.37%
1-Tages-Spanne:
$14.39
$16.24
1-Wochen-Bereich:
$13.27
$16.75
52-Wochen-Spanne:
$12.17
$44.78
Fmc Corp Stock (FMC) Company Profile
Firmenname
Fmc Corp
Sektor
Branche
Telefon
215-299-6668
Adresse
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
14.53 | 2.00B | 4.17B | 1.46B | 493.00M | 11.62 |
|
CTVA
Corteva Inc
|
74.11 | 50.63B | 17.40B | 1.20B | 2.82B | 1.5836 |
|
NTR
Nutrien Ltd
|
70.43 | 35.32B | 26.62B | 1.84B | 2.16B | 3.711 |
|
CF
Cf Industries Holdings Inc
|
94.16 | 15.12B | 6.74B | 1.70B | 1.71B | 8.2952 |
|
MOS
Mosaic Company
|
29.77 | 9.88B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
5.73 | 7.42B | 6.84B | 407.00M | 755.00M | 0.32 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-11-11 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-31 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-06-23 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-25 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2025-02-14 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-07 | Herabstufung | UBS | Buy → Neutral |
| 2025-02-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-21 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-01-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-23 | Eingeleitet | Citigroup | Neutral |
| 2024-06-26 | Eingeleitet | Barclays | Equal Weight |
| 2024-03-01 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-02-12 | Herabstufung | Loop Capital | Buy → Hold |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-01-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-01-04 | Eingeleitet | ROTH MKM | Buy |
| 2023-12-14 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-12-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-10-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-10-24 | Herabstufung | Goldman | Buy → Neutral |
| 2023-10-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-10-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-09-25 | Herabstufung | Redburn Atlantic | Overweight → Neutral |
| 2023-09-05 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-21 | Eingeleitet | JP Morgan | Neutral |
| 2023-08-04 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2023-07-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-17 | Hochstufung | Redburn | Neutral → Buy |
| 2023-01-19 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-07-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-06-21 | Hochstufung | BofA Securities | Underperform → Buy |
| 2022-06-13 | Herabstufung | Redburn | Buy → Neutral |
| 2022-05-31 | Eingeleitet | Credit Suisse | Underperform |
| 2022-04-14 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-03-31 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2022-03-22 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-02-10 | Bestätigt | Citigroup | Buy |
| 2022-02-10 | Bestätigt | Mizuho | Buy |
| 2022-02-10 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2022-02-10 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-31 | Eingeleitet | Redburn | Buy |
| 2022-01-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-10-18 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-24 | Herabstufung | Vertical Research | Buy → Hold |
| 2021-05-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-02-11 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2020-09-17 | Eingeleitet | UBS | Buy |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-10-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-16 | Eingeleitet | Wells Fargo | Outperform |
| 2019-09-18 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2019-08-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-08-02 | Hochstufung | Goldman | Neutral → Buy |
| 2019-08-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-13 | Fortgesetzt | Citigroup | Buy |
| 2019-05-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-04-18 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-03-21 | Bestätigt | Jefferies | Buy |
| 2019-03-08 | Fortgesetzt | Goldman | Neutral |
| 2018-11-14 | Eingeleitet | Buckingham Research | Buy |
| 2018-11-09 | Fortgesetzt | Loop Capital | Buy |
| 2018-11-05 | Fortgesetzt | Citigroup | Buy |
| 2018-11-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-05-14 | Hochstufung | Goldman | Neutral → Buy |
| 2018-05-04 | Hochstufung | Stephens | Equal-Weight → Overweight |
Alle ansehen
Fmc Corp Aktie (FMC) Neueste Nachrichten
FMC Posts $2.2 Billion Loss, Launches Strategic Review Including Possible Sale - PHILADELPHIA.Today
FMC (FMC) expects tariff headwinds for Q1 as Q4 earnings slip - MSN
FMC Weighs Full Sale As Debt Pressures And Patent Risks Mount - simplywall.st
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Bank of America Global Agriculture and Materials Conference - Finviz
FMC (FMC) Expects Tariff Headwinds for Q1 as Q4 Earnings Slip - Finviz
FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut - TechStock²
FMC Corp Earnings Call Maps Difficult Transition Year - TipRanks
10 Best High-Upside Materials Stocks to Buy - Insider Monkey
FMC Maintained at Neutral by Citigroup; Price Target Lowered to $14 | FMC Stock News - GuruFocus
Breaking Down FMC: 11 Analysts Share Their Views - Benzinga
FMC price target lowered to $16 from $17 at BofA - TipRanks
FMC’s Strategic Initiatives Promise Debt Reduction and Growth - StocksToTrade
FMC Corp: Chemical Contender Stages a Tentative Rebound as Wall Street Stays Cautious - AD HOC NEWS
FMC Corporation (FMC): A Bull Case Theory - Finviz
FMC Strengthens 2026 Vision with Bold Debt Reduction, Innovation Plans - timothysykes.com
FMC price target lowered to $15.50 from $17 at Morgan Stanley - Yahoo Finance
FMC Corporation (NYSE:FMC) Q4 2025 Earnings Call Transcript - Insider Monkey
FMC Corporation Just Hit the Panic Button—Sale, Spin-Offs, or Shutdown? - Smartkarma
FMC's Price Target Lowered by RBC Capital: Today's Analyst Insig - GuruFocus
Wells Fargo Maintains FMC Rating, Lowers Price Target | FMC Stoc - GuruFocus
UBS Adjusts Price Target on FMC to $14 From $15, Maintains Neutral Rating - marketscreener.com
Morgan Stanley Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $15.5 - 富途牛牛
Morgan Stanley Lowers FMC (NYSE:FMC) Price Target to $15.50 - MarketBeat
Wells Fargo Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14 - 富途牛牛
BMO Capital Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $15 - 富途牛牛
UBS Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14 - 富途牛牛
FMC Q4 Earnings Call Highlights - Yahoo Finance
Top 3 Materials Stocks That May Rocket Higher This Month - Benzinga
FMC Board Reviews Sale Options As Valuation Gap And Risks Emerge - Yahoo Finance
Research Alert: CFRA Reiterates Strong Sell Opinion On Shares Of Fmc Corporation - 富途牛牛
FMC Corp. Stock Just Got Cheaper – Is This Quiet Crash Actually a Power Move? - AD HOC NEWS
FMC Corp (FMC) Q4 2025 Earnings Call Highlights: Strategic Moves Amidst Declining Sales - GuruFocus
FMC Corp (FMC) Q4 2025 Earnings Call Highlights: Strategic Moves Amidst Declining Sales By GuruFocus - Investing.com Canada
FMC downgraded to junk status by Moody’s amid patent challenges - Investing.com
FMC Considering Asset Sales or Potential Sale of Company to Reduce Debt - Morningstar
FMC outlines $1B debt reduction and explores sale, projects $3.6B–$3.8B 2026 sales amid strategic review - MSN
Why FMC Corporation Plunged Today - Yahoo Finance
FMC (FMC) Is Up 6.1% After Board Explores Sale Amid Debt Cuts And Pipeline Reset - Yahoo Finance
FMC : Fourth Quarter 2025 Transcript - marketscreener.com
FMC Corp Stock: Deep-Value Chemistry Play Or Value Trap After A Brutal Slide? - AD HOC NEWS
FMC Corp. to explore strategic options, including possible sale - MSN
FMC (FMC) Shares Experience Significant Drop - GuruFocus
FMC Q4 2025 slides: revenue declines as company explores strategic options - Investing.com
Earnings call transcript: FMC Q4 2025 results reveal revenue shortfall By Investing.com - Investing.com India
Chitosan Market to Reach Over US$ 8.6 Billion by 2035 Driven by Green Chemistry Mandates, Pharmaceutical-Grade Demand, and Vegan Fungal Sourcing | Astute Analytica - GlobeNewswire Inc.
Earnings call transcript: FMC Q4 2025 results reveal revenue shortfall - Investing.com
FMC's Q4 Earnings and Revenues Miss Estimates on Lower Prices - Yahoo Finance
FMC Faces Financial Turmoil Amid Strategic Reviews - StocksToTrade
FMC Corp. explores sale following $2.2B loss - The Business Journals
BofA Securities Maintains FMC Corp(FMC.US) With Hold Rating, Maintains Target Price $17 - 富途牛牛
FMC Sets 2026 Priorities and Explores Strategic Options Amid Portfolio Transition - iGrow News
Finanzdaten der Fmc Corp-Aktie (FMC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
8.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):